The Role of Upadacitinib in Refractory Dermatomyositis: A Systematic Review
收藏Mendeley Data2026-04-09 收录
下载链接：
https://data.mendeley.com/datasets/24vtbhd83t
下载链接
链接失效反馈官方服务：
资源简介：
Recent reports highlight upadacitinib, a JAK inhibitor that is highly selective for JAK1, as a promising treatment when used off-label for dermatomyositis. This systematic review aims to investigate upadacitinib as a therapy for refractory dermatomyositis.
